Navigation Links
Celtaxsys Announces Successful Completion of Phase 1 Clinical Trial for Development of CTX-4430
Date:9/16/2013

ATLANTA, Sept. 16, 2013 /PRNewswire/ -- Atlanta-based pharmaceutical discovery and development company, Celtaxsys, Inc., announced today the achievement of a significant clinical milestone for its lead clinical stage drug candidate, CTX-4430, for treatment of Cystic Fibrosis (CF) lung disease. Celtaxsys has successfully completed the first of two clinical trials in its Phase 1 program, and the first trial conducted through its Australia subsidiary, Celtaxsys Aus Pty Ltd. In this First-in-Human trial, CTX-4430 was administered orally to Healthy Volunteers in escalating doses (up to 200 mg/day for 2 weeks) and was well-tolerated at all doses. Results of the trial will be presented at the 27th Annual North American Cystic Fibrosis Conference in October.

"This was a robust First-in-Human clinical trial assessing safety in 96 subjects. We're very pleased with the safety outcomes of CTX-4430 in this Healthy Volunteer study," said Dr. Ed Philpot, Celtaxsys CMO.  "These results support the continued clinical development of CTX-4430 as a once-daily oral treatment for pulmonary inflammation in CF."

CTX-4430 also exhibited excellent pharmacokinetic and pharmacodynamic properties in this study. "The 100 mg dose achieved maximal effect on its intended target, Leukotriene A4 Hydrolase, for the entire 24 hour period between doses," said Dr. Eric Springman, Celtaxsys CSO. "Having a biomarker to directly probe mechanism of action provides us with a much better understanding of the relationship between dose and effect and will be a tremendous help in the further clinical development of CTX-4430."

Said Mr. Ralph Grosswald, VP of Operations at Celtaxsys, "We had a great experience conducting our initial Phase 1 study of CTX-4430 in Australia. The entire process from start to fini
'/>"/>

SOURCE Celtaxsys, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Celtaxsys Restructures, Enhances Operational Focus
2. Freudenberg-NOK Sealing Technologies Announces Screw Connections Based on Hygienic Design Consistently Achievable
3. Plastic Surgeon Dr. Marc J. Salzman Announces Use of Astanza Trinity Laser Tattoo Removal System, Runs Limited-Time Promotion
4. Sam Solakyan announces Paramount Management Services is now a full-scale MSO
5. Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
6. Cell Therapeutics Announces Sale of Convertible Preferred Stock
7. Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
8. Goodwin Biotechnology Announces the Appointment of SooYoung S. Lee, PhD as Chief Operating Officer
9. Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
10. Egalet Announces Financing to Fund Abuse-Deterrent Medications
11. PRA Holdings Announces Proposed Private Offering of $375 Million Senior Notes Due 2023
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... --  DaVita HealthCare Partners Inc.  (NYSE: ... most innovative health care communities, today announced that ... Research  (DCR) and  HealthCare Partners Clinical Research , will ... research and data analytics services, specifically in patients ... disease (ESRD), as well as primary care and ...
(Date:12/13/2014)... Dec. 11, 2014 Research and Markets ... of the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new ... expanding list of health conditions, drug developers have ... the administration process and increase the efficiency and ...
(Date:12/13/2014)... 2014 Mindray Medical International Limited ("Mindray", NYSE: ... marketer of medical devices worldwide, today announced shareholder resolutions ... in Hong Kong on December ... voted to re-elect incumbent directors Li Xiting and Kern ... did not re-elect Peter Wan as a ...
Breaking Medicine Technology:DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
... , NANJING, China, ... "Company") (NYSE: SCR ), a leading pharmaceutical ... and proprietary pharmaceuticals in China, today reported that its,subsidiary ... suspended production of all its products in order to ...
... Calif., Dec. 1 Patient Safety Technologies, Inc. (OTC ... Marc L. Rose, CPA(PA), to the position of Chief ... Lay, who has been acting CFO since 2008. ... was Vice President Finance, Chief Financial Officer, Treasurer and ...
Cached Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2
(Date:12/17/2014)... San Francisco, CA (PRWEB) December 17, 2014 ... the Stanford Center for Longevity, today, in reaction to a ... the emerging science of brain training and derogated the efficacy ... said that they agreed with the parts of the center’s ... however, they believed the center had also overstated its case, ...
(Date:12/17/2014)... 15, 2014 (HealthDay News) -- As gas prices rose ... a new study suggests. In times of gas ... those riders are inexperienced, the researchers explained. They ... which has the highest number of motorcycle registrations in ... motorcyclist deaths. The analysis revealed a strong association ...
(Date:12/17/2014)... By Alan Mozes ... -- With the holiday party season fast approaching, a new ... and make DUI arrests have fewer drunk drivers on their ... driving laws more vigilantly are better able to deter inebriated ... "Hardly any new laws are being passed regarding drinking ...
(Date:12/15/2014)... 15, 2014 Veretekk.com, Inc. announced today ... Avenue. JM Ocean Avenue has secured exclusive benefit ... automated marketing system. JM Ocean Avenue is a ... of Ocean Avenue and JM International, with partial ownership ... per year company. , “After nearly 2 decades of ...
(Date:12/15/2014)... Boston, MA (PRWEB) December 15, 2014 ... health management solutions, announced today that it has ... for Quality Assurance (NCQA) for its Disease Management ... obstructive pulmonary disease (COPD), coronary heart disease and ... accreditation from NCQA for Health Dialog’s Disease Management ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2
... N.Y. -- Increases in young womens drinking during the ... college can have dangerous physical, sexual and psychological implications, ... Buffalos Research Institute on Addictions. , The good news ... many young women increase their drinking, the majority (78 ...
... Despite Difficulties, States Rise Against the Status Quo ... - A new report from the,Robert Wood Johnson ... 2008: Rising to the Challenge, outlines 2007 efforts ... to address health care,reform at the state level. ...
... Feb. 8 Corbett Worldwide Healthcare,Communications launched a ... glimpse of how the Chicago agency combines passion, ... soar. The new site was announced,today at the ... http://www.newscom.com/cgi-bin/prnh/20080208/AQF005 ), "Our Web site reflects ...
... Study finds spouses die sooner in unions where anger is ... the secret to a long marriage is communication, and new ... life. , A lengthy study of Midwestern couples finds that ... than the perennially resentful. The couples with the most unexpressed ...
... be the only one if its kind in the ... Cancer Care Alliance (SCCA),and Northwest Hospital & Medical Center ... explore the development of a new, state-of-the-art,cancer treatment facility ... its intention to develop a proton-therapy,facility in September 2006 ...
... Symmetry Medical Inc.,(NYSE: SMA ), a leading ... and other medical markets, today announced it,will provide a ... 14, 2008 before the opening of the U.S. financial ... 8:00 a.m. ET on,February 14, 2008., A live ...
Cached Medicine News:Health News:A dangerous transition: High school to the first year of college 2Health News:A dangerous transition: High school to the first year of college 3Health News:A dangerous transition: High school to the first year of college 4Health News:Report Lists Key Policy Questions Facing State, National Health Reform 2Health News:Report Lists Key Policy Questions Facing State, National Health Reform 3Health News:Report Lists Key Policy Questions Facing State, National Health Reform 4Health News:Corbett Worldwide Healthcare Communications' New Web Site Demonstrates How Fresh Ideas 'Blow In' From Chicago 2Health News:Mutual Resentment in Marriage Can Be Deadly 2Health News:Mutual Resentment in Marriage Can Be Deadly 3Health News:Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment 2Health News:Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment 3Health News:Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008 2
... Stainless steel workbench top with ... adjustable from 25"-34". Available in ... Accessories include shelves, drawers, light ... is an expert in custom ...
... is configured specifically for pharmaceutical powder ... Panels are precision-joined to create ultra-smooth ... down and disinfect. One-inch radius corners ... creates strong, rigid surface without external ...
... Cleanroom-grade vinyl curtains or parting ... steel support frame to form ... that meets cleanliness to Class ... filter/fan units, lights, and ionizers ...
Inquire...
Medicine Products: